爱美客(300896.SZ)：公司独家经销进口产品获得药品注册证书

Group 1 - The core viewpoint of the article is that Aimeike (300896.SZ) has received approval from the National Medical Products Administration for the drug registration certificate of its exclusive distribution of injectable type A botulinum toxin products produced by Huons BioPharma Co., Ltd. in China, including Macau and Hong Kong [1] - The acquisition of the drug registration certificate for the injectable type A botulinum toxin product is a key milestone in the company's strategic layout [1] - This product, combined with existing offerings, will provide customers with a more comprehensive solution, enhancing the company's core competitiveness [1]